Rajat Bose of rajatkbose.com advises holding Jubilant Life Sciences.
Rajat Bose of rajatkbose.com told CNBC-TV18, "Once Jubilant Life Sciences has cleared Rs 775 or so, I think the next target would be something like Rs 823 and I suppose the price is already too close to that. So, one can continue to hold on with Rs 775 as the stoploss here."He further added, "It is giving a breakout after quite a few months, in fact it is already on a 2017 high and also if I am not mistaken an all-time high. So, the stock looks pretty good, so continue holding on."